Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
6.15
+0.22 (3.71%)
Dec 20, 2024, 4:00 PM EST - Market closed
Pulmonx Market Cap
Pulmonx has a market cap or net worth of $242.85 million as of December 20, 2024. Its market cap has decreased by -46.14% in one year.
Market Cap
242.85M
Enterprise Value
190.88M
1-Year Change
-46.14%
Ranking
Category
Stock Price
$6.15
Market Cap Chart
Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $1.33B to $242.85M, a decrease of -81.79%. That is a compound annual growth rate of -33.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 242.85M | -50.28% |
| Dec 29, 2023 | 488.43M | 54.88% |
| Dec 30, 2022 | 315.36M | -73.31% |
| Dec 31, 2021 | 1.18B | -52.01% |
| Dec 31, 2020 | 2.46B | 84.60% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rezolute | 245.10M |
| Abeona Therapeutics | 244.74M |
| Artiva Biotherapeutics | 242.89M |
| Anika Therapeutics | 239.16M |
| High Tide | 238.30M |
| Heron Therapeutics | 232.71M |
| Electromed | 232.43M |
| BGM Group | 231.43M |